You’ve probably heard that even the longest journey begins with a single step. Those who completed the American Lung Association’s Fight for Air Climb in Philadelphia took that first step and then 1,087 more – up 50 flights to the top of 3 Logan Square.
Among this year’s participants were CSL employees based in the Philadelphia area. CSL climbers who couldn’t attend in person participated virtually from Houston, Texas, Boston, Massachusetts, and Marburg, Germany.
The vertical challenge, held in numerous U.S. cities every year, aims to bring attention to respiratory conditions and the importance of healthy lungs. CSL, a global biotech company, includes CSL Behring, a business unit with headquarters in King of Prussia, Pennsylvania, which develops and manufactures medicines for conditions including Alpha 1 Antitrypsin Deficiency. CSL is also researching potential new treatments for lung diseases and supporting a consortium of researchers using artificial intelligence to improve outcomes.
Watch TV news coverage of the April 22 event in Philadelphia.
Here are photos from Ron Chamrin, who organized the CSL team and is a Global Regulatory Lead for three of CSL’s Respiratory programs.
The view from the top of 3 Logan Square in Philadelphia, the site of the American Lung Association’s Fight for Air Climb, was one of the rewards for getting to the finish line.
Ellyn Getz, Director of R&D Patient Partnerships, was out of town but participated by climbing 50 flights in Houston, Texas.
Chamrin and volunteer Jesse Crew, CSL’s Director of R&D Enabling Technology, Information Management, at the finish line.
